Traditional Wound Care Market in Asia Pacific 2023
The traditional wound care product market is experiencing growth due to various factors such as the rise in prevalence of acute and chronic wounds, the use of traditional wound care products in surgical wounds, and the expansion of the aging population. Traditional wound care products are in demand from outpatient centers due to their lower cost and availability compared to advanced wound care products. In 2022, the traditional wound care market in Asia Pacific stood at USD 928 million. Recording a CAGR of 5% from 2023 to 2028, the worth is projected to reach ~USD 1,234 million by 2028, according to the latest market data.
The report provides up-to-date market size data for period 2019-2022 and forecast to 2028 covering key market aspects like sales value and volume for traditional wound care. The Asia Pacific traditional wound care market is segmented on the basis of product, retail channel, and country. By product, the traditional wound care market in Asia Pacific has been segmented into adhesive bandages, first aid kits, and gauze pads & tapes. According to the research, the adhesive bandages segment had the largest share in the traditional wound care market in Asia Pacific. Based upon retail channel, the traditional wound care market in Asia Pacific is categorized into convenience stores, drug stores and pharmacies, e-commerce, grocery stores, supermarkets and hypermarkets, and others. In terms of geography, the traditional wound care market in Asia Pacific has been segmented into Australia, China, India, Indonesia, Japan, Philippines, South Korea, Thailand, Vietnam, and others.
The Asia Pacific traditional wound care market is highly competitive. Top players covered in Asia Pacific Traditional Wound Care Market Study are 3M Company, Band Doctor Co. Ltd., Beiersdorf AG, CG Bio Inc., Convatec Group plc, Forest Holdings Inc., Fujimoto Holdings Co. Ltd., Glory Ray Holdings Limited, Hakujuji Co. Ltd., Ildong Pharmaceutical Co. Ltd., Jack Chia Industries (Thailand) Public Company Limited, Johnson & Johnson (J&J), JW Shinyak Corporation, Kobayashi Pharmaceutical Co. Ltd., Mundipharma International Limited, NICHIBAN Co. Ltd., Paul Hartmann AG, Sato Pharmaceutical Co. Ltd., SinSin Pharmaceutical Co. Ltd., Smith & Nephew plc, Yunnan Baiyao Group Co. Ltd., Yutoku Pharmaceutical Ind Co. Ltd.
The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the traditional wound care market to help drive informed decision making for industry executives, policy makers, academic, and analysts.
Product: adhesive bandages, first aid kits, and gauze pads & tapes
Retail channel: convenience stores, drug stores and pharmacies, e-commerce, grocery stores, supermarkets and hypermarkets, and others
Country: Australia, China, India, Indonesia, Japan, Philippines, South Korea, Thailand, Vietnam, and others
Years considered: this report covers the period 2019 to 2028
Key Benefits for Stakeholders
Get a comprehensive picture of the Asia Pacific traditional wound care market
Identify regional strategies and strategic priorities on the basis of local data
Pinpoint growth sectors and trends for investment
Table of Contents
1. Market definition
2. Research methodology
3. Market overview
4. Traditional wound care market by product
4.1 Adhesive bandages
4.2 First aid kits
4.3 Gauze pads & tapes
5. Traditional wound care market by retail channel
5.1 Convenience stores
5.2 Drug stores and pharmacies
5.4 Grocery stores
5.5 Supermarkets and hypermarkets
6. Traditional wound care market by country
6.7 South Korea
7. Company profiles
7.1 3M Company
7.2 Band Doctor Co. Ltd.
7.3 Beiersdorf AG
7.4 CG Bio Inc.
7.5 Convatec Group plc
7.6 Forest Holdings Inc.
7.7 Fujimoto Holdings Co., Ltd.
7.8 Glory Ray Holdings Limited
7.9 Hakujuji Co., Ltd.
7.10 Ildong Pharmaceutical Co., Ltd.
7.11 Jack Chia Industries (Thailand) Public Company Limited
7.12 Johnson & Johnson (J&J)
7.13 JW Shinyak Corporation
7.14 Kobayashi Pharmaceutical Co., Ltd.
7.15 Mundipharma International Limited
7.16 NICHIBAN Co., Ltd.
7.17 Paul Hartmann AG
7.18 Sato Pharmaceutical Co., Ltd.
7.19 SinSin Pharmaceutical Co., Ltd.
7.20 Smith & Nephew plc
7.21 Yunnan Baiyao Group Co., Ltd.
7.22 Yutoku Pharmaceutical Ind Co., Ltd.
8.1 About StrategyHelix